Investornewsbreaks Nurexone Biologic Inc. (TSX.V: NRX) (OTCQB: NRXBF) To Highlight Exosome Technology, Pipeline And US Initiatives At NY Conference

(MENAFN- Investor Brand Network) Disseminated on behalf of NurExone Biologic Inc. (TSX.V NRX) (OTCQB:NRXBF) and may include paid advertising.

NurExone Biologic (TSX.V NRX) (OTCQB:NRXBF) will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9-10 in New York City. Yoram Drucker, the company's co-founder and chairman, is scheduled to present to investors and conduct one-on-one meetings. NurExone plans to use the event to showcase its exosome-based therapeutic platform, development pipeline, and U.S. manufacturing and commercialization initiatives as it advances preclinical programs and prepares for potential clinical development.

To view the full press release, visit

About NurExone Biologic Inc.

NurExone Biologic is a biotechnology company focused on developing regenerative exosome-based therapies for central nervous system injuries. Its lead candidate, ExoPTEN, has shown strong preclinical potential in treating acute spinal cord and optic nerve damage, and the company also aims to supply quality exosomes and minimally invasive targeted delivery systems while anchoring its North American strategy through its Exo-Top platform.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: /Disclaimer

InvestorWire
Austin, Texas

512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

MENAFN01092026000224011066ID1111608143